Domain | Time | Group | Unadjusted p-value | Adjusted p-value | |
Mate Endurance (n = 32) | Placebo (n = 30) | ||||
Sexual Satisfaction | Start of intervention | 26.6 ± 9.1 25.0 (12.5 - 50.0) | 25.2 ± 4.8 25.0 (18.7 - 37.5) | 0.547a | <0.001b |
12 weeks past intervention | 44.7 ± 14.3 50.0 (25.0 - 68.7) | 30.0 ± 9.9 25.0 (12.5 - 50.0) | <0.001a | ||
Mean differential | 18.2 ± 16.3 15.6 (0.0 - 43.7) | 4.8 ± 11.1 0.0 (−12.5 - 31.2) | <0.001a |
| |
p-value | <0.001c | 0.033c |
|
| |
| Start of intervention | 10.3 ± 9.1 6.2 (0.0 - 25.0) | 11.7 ± 6.7 12.5 (0.0 - 25.0) | 0.397a | 0.524b |
Control | 12 weeks past intervention | 17.2 ± 8.2 18.7 (0.0 - 25.0) | 16.7 ± 8.3 18.7 (0.0 - 31.2) | 0.705a | |
| Mean differential | 6.8 ± 8.6 3.1 (0.0 - 25.0) | 5.0 ± 7.7 0.0 (−6.2 - 18.7) | 0.401a |
|
| p-value | <0.001c | 0.003c |
|
|
| Start of intervention | 9.8 ± 9.9 12.5 (0.0 - 25.0) | 11.7 ± 9.2 12.5 (0.0 - 25.0) | 0.403a | <0.001b |
Distress | 12 weeks past intervention | 31.6 ± 17.4 25.0 (0.0 - 50.0) | 18.3 ± 10.7 25.0 (0.0 - 25.0) | 0.005a | |
| Mean differential | 21.9 ± 17.7 18.7 (0.0 - 50.0) | 6.7 ± 12.2 0.0 (−12.5 - 25.0) | 0.001a |
|
| p-value | <0.001c | 0.007c |
|
|